Jefferies Financial Group Inc. Insmed Inc Call Options Transaction History

Jefferies Financial Group Inc.

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 13, 2024	BUY	$22.0 - $69.71 $48,400 - $153,362	2,200 Added 41.51%	7,500 $502,000
Q1 2024 May 13, 2024	BUY	$25.72 - $29.94 $56,584 - $65,868	2,200 Added 70.97%	5,300 $143,000
Q4 2023 Feb 13, 2024	BUY	$23.42 - $31.74 $2,342 - $3,174	100 Added 3.33%	3,100 $96,000
Q3 2023 Nov 14, 2023	BUY	$19.86 - $26.93 $59,580 - $80,790	3,000 New	3,000 $75,000

447

170M

5.79M

5.18M

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $9.82B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

Stay updated on Jefferies Financial Group Inc. with notifications on news.